DIVING INTO THE BRAIN

DeepPulseNeuro will provide the standard technique for measuring electrical brain activity.

Thanks to our device and the endovascular approach, commonly used in cardiovascular procedures or stroke treatment using stents, the electroencephalogram (EEG) will be measured deep into the brain, as close as possible to the areas responsible for epilepsy.

By traveling through the cerebral vessels, without perforating the skull, DeepPulseNeuro will provide a safe, accessible, and clinically relevant channel that can transform the epilepsy care.

DeepPulseNeuro won the i-Lab 2025 France Innovation Competition.

EPILEPSY IS AN INVISIBLE THREAT

DeepPulseNeuro aims to transform their care

A NEW APPROACH TO EPILEPSY TREATMENT

Our minimally invasive intracranial endovascular monitoring technology will enable*:

*pending clinical evidence

COMPLEMENTARY SKILLS AND EXPERIENCE

DeepPulseNeuro is equiped to identify market needs, optimize development stages, and provide timely access to our technology for epilepsy patients and their caregivers in both Europe and the United States, while ensuring the robustness of our organization.

Stéphane Corp

CEO
CO FOUNDER

Stéphane brings his 25 years of
experience in the medical device industry to DeepPulseNeuro. He has previously held various leadership positions in European start-ups and an American multinational. He has lived and worked in Morocco, the United
States, and France. He has led and developed multicultural and multi-skilled teams. His core competencies include business strategy development, sales network development, new product launches, and medical training organization. He is a cofounder and investor in the
American (originally French) start-up
Hyprevention Inc. He is an international
consultant in the field of health.

Stéphane serves as French Foreign
Trade Advisor.

Pierre-Henri Lefèvre, MD

MEDICAL DIRECTOR
CO FOUNDER

Pierre-Henri is an interventional neuroradiologist who specializes in epilepsy, neuroradiology, and medical imaging. He holds a European Diploma in Neuroradiology and has extensive clinical experience in France. His research contributions cover neurovascular procedures and advanced techniques for treating strokes, and he has numerous publications to support his work. He brings solid experience in medical innovation, particularly in diagnostic and therapeutic neuroradiology. He serves in the Department of Cerebral Endovascular Medicine at Montpellier University Hospital.

Vincent Serantoni, Ph.D.

R&D PROJECT MANAGER
CO FOUNDER

Vincent Serantoni holds a Ph.D. in biomechanics and has conducted several research projects on characterizing the human body using experimental and numerical methods. His six years of experience in public research have led him to collaborate closely with hospitals and clinicians, oversee the formation of human protection committees, and publish numerous scientific articles in the health field.

Serge Bernard,PhD.

SCIENTIFIC ADVISOR
CO FOUNDER

Serge Bernard is a CNRS research director who specializes in microelectronics and sensor systems. He has led major research initiatives, including the development of tools for observing ocean biodiversity and innovative electronic devices for medical applications. With a Ph.D. in electronics from the University of Montpellier and over 25 years of experience, he bridges the gap between academic research and practical technological applications. He has managed large-scale projects, edited international publications, and made significant contributions to scientific advances in sensor technology for living organisms and machine learning.

Koji Andriamahery

R&D ENGINEER
EMBEDDED ELECTRONICS

Koji is an engineer with dual degrees in mechatronics from the Ecole des Mines and in healthcare devices from the University of Montpellier. With four years of experience in industrial R&D, he specializes in embedded electronics for medical devices. Accustomed to working in multidisciplinary teams, his contributions have led him to work directly with patients, hospital practitioners, and medical biologists. His projects have enabled him to cover the entire physiological signal chain, from acquisition at the patient’s bedside to software exploitation by healthcare professionals.

Marjory Mayo

ORGANIZATIONAL ENGAGEMENT & ROBUSTNESS CONSULTANT / FOUNDER OF MAILLE & CO

Marjory combines a background in socio-economic management with over a decade of experience in quality systems and workplace development within medical device industries and collaborative environments. Today, she helps organizations strengthen their robustness by activating two essential levers: desirability and engagement. Founder of Maille & Co, she promotes a pragmatic and human-centered approach to corporate responsibility, rooted in relational intelligence. Her work focuses on helping leaders build organizations where people genuinely want to commit — and can sustainably thrive.

Stéphanie Garbez

SENIOR CONSULTANT, R&D, QARA / FOUNDER OF MEDINQARA

Over the past 25 years, Stéphanie Garbez has worked as an audit manager for a notified body and as a technical manager for a national testing laboratory. She obtained two COFRAC accreditations in this role. She has also held positions of responsibility within international groups, including Design and Testing Laboratories Quality Manager and Quality and Regulatory Affairs Global Director. These experiences have enabled her to develop extensive expertise in medical device evaluation, quality system and technical documentation audits, quality system management, and technical documentation development and review.

OUR SOCIAL AND ENVIRONMENTAL COMMITMENTS

Our purpose is to develop breakthrough medical technologies and access platforms that improve the understanding, diagnosis, and treatment of neurological disorders. Our ethical, responsible, and robust approach fuels our ambition to benefit patients, caregivers, and healthcare professionals.

Our primary goal is to transform epilepsy management and restore hope to the millions of people who currently have no treatment options for their condition.

PARTNERS